Enfortumab vedotin plus pembrolizumab not only beat chemotherapy in the first-line setting for locally advanced metastatic urothelial cancer for the first time in decades, but it nearly doubled ...
Tuko News on MSN
Cancer survivor celebrates full recovery 6 years after chemotherapy, shares message of hope
Six years after her first chemotherapy treatment, Yasmine Allela reflects on her cancer journey, celebrating healing, faith, ...
The European Commission has approved Tagrisso (osimertinib; AstraZeneca) combined with pemetrexed and platinum-based chemotherapy for the first-line treatment of adult patients with advanced epidermal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results